openPR Logo
Press release

Brucellosis Vaccines Market to Grow Amid Rising Livestock Health Campaigns and Technological Advancements| Forecast Period: 2024 - 2031

05-19-2025 01:00 PM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Brucellosis Vaccines Market

Brucellosis Vaccines Market

Brucellosis Vaccines Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new opportunities in today's rapidly evolving global landscape.

Brucellosis Vaccines Market is expected to Grow at a CAGR of 4.5% during the forecast period 2024-2031.

Request a Premium Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/brucellosis-vaccines-market?sv

Market opportunities and Growth Drivers:

Ongoing initiatives by key players, such as awareness programs and vaccination campaigns in underdeveloped regions, are driving the brucellosis vaccines market by improving livestock health and disease prevention. Growth opportunities lie in expanding vaccination coverage in emerging economies and addressing access challenges through partnerships, government schemes, and global health alliances.

Brucellosis Vaccines Market Recent Development:

May 2023 - ICAR launched a new Brucella vaccine (S19Δ per) with improved immunity and fewer side effects, supporting India's national brucellosis control efforts.

August 2023 - Zoetis expanded vaccine production in Latin America, focusing on brucellosis vaccines to meet rising demand from regional animal health programs.

List of the Key Players in the Brucellosis Vaccines Market:

AbbVie, Inc., AstraZeneca PLC, Bayer AG, BeiGene, CARsgen Therapeutics, CStone Pharmaceuticals Co., Ltd. and GlaxoSmithKline PLC, among others.

Assessing the Effects of U.S. Tariffs on the Brucellosis Vaccines Market

The U.S. tariff war is reshaping how businesses analyze trends and make strategic decisions. As tariffs drive up costs and disrupt supply chains, companies are increasingly focused on understanding consumer behavior, identifying new sourcing opportunities, and adjusting their operations to remain competitive. The ongoing uncertainty has created a stronger demand for timely insights and data-driven strategies to navigate shifting trade dynamics and economic pressures.

Research Process:

Both primary and secondary data sources have been used in the global Brucellosis Vaccines Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/brucellosis-vaccines-market?sv

Segment Covered in the Brucellosis Vaccines Market:

By Species - Sheep, Cattle, Goat

By Treatment - Antibiotics, Vaccines

By Diagnosis - Serological Tests, Molecular Techniques, Bone Marrow Biopsy, Magnetic Resonance Imaging (MRI), Others

Regional Analysis for Brucellosis Vaccines Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

People Also Ask:

Most Frequently Asked Questions in the Brucellosis Vaccines Market Research Industry:

➠ What are the global figures for sales, production, consumption, imports, and exports in the Brucellosis Vaccines market?

➠ Who are the top manufacturers in the global Brucellosis Vaccines industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?

➠ What key opportunities are available for vendors in the Brucellosis Vaccines market, and what challenges are they likely to encounter?

➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?

➠ What are the major drivers and barriers influencing the growth trajectory of the Brucellosis Vaccines market?

➠ What are the primary sales, marketing, and distribution strategies used across the global Brucellosis Vaccines industry landscape?

Browse More Reports: https://www.datamintelligence.com/research-report/brucellosis-vaccines-market?sv

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Brucellosis Vaccines Market to Grow Amid Rising Livestock Health Campaigns and Technological Advancements| Forecast Period: 2024 - 2031 here

News-ID: 4023257 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Mushroom Extracts Market 2031 | Growth Drivers, Key Players & Investment Opportunities
United States Mushroom Extracts Market 2031 | Growth Drivers, Key Players & Inve …
Market Size and Growth The Global Mushroom Extracts Market reached US$ 5.8 billion in 2022 and is expected to reach US$ 11.4 billion by 2030, growing with a CAGR of 8.7% during the forecast period 2024-2031. Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/mushroom-extracts-market?sb Key Development: United States: Recent Mushroom Extracts Developments ✅ In December 2025, KÄÄPÄ Biotech secured a €9 million investment to scale production capacity
United States Anti-Aging Market | CAGR 7.7% | North America Leads with 35% Share | Key Players: Lonza, L'Oréal, Beiersdorf, Estée Lauder, Procter & Gamble, Shiseido, Unilever, WEI Beauty, Xi'an Tian Guangyuan Biotech
United States Anti-Aging Market | CAGR 7.7% | North America Leads with 35% Share …
Market Overview The global Anti-Aging Market is projected to grow at a CAGR of 7.7% during the forecast period 2024-2031. Anti-aging refers to techniques, products, and interventions designed to slow, prevent, or reverse the signs of aging, helping individuals maintain a youthful appearance and optimal biological function. Anti-aging products target both internal and external biochemical processes associated with aging. Internally, these products aim to support cellular health, reduce oxidative stress, and enhance
Canada Anti-Aging Products Market to Reach USD 1,247.02 Million by 2032 | CAGR 5.82% | North America Leads with 70% Share | Key Players: L'Oréal, Estée Lauder, Procter & Gamble, Shiseido, Johnson & Johnson, Unilever, Yves Rocher, La Prairie, Natura Bi
Canada Anti-Aging Products Market to Reach USD 1,247.02 Million by 2032 | CAGR 5 …
Market Overview The Canada anti-aging products market reached US$793.11 million in 2024 and is projected to grow to US$1,247.02 million by 2032, registering a CAGR of 5.82% during the forecast period 2025-2032. Market growth is largely driven by Canada's aging population and a rising consumer focus on health, wellness, and longevity. According to Statistics Canada, the number of individuals aged 65 and older has been steadily increasing, reflecting a demographic shift
Microneedles Drug Delivery Market | CAGR 6.6% | North America Leads with 35% Share | Key Players: 3M, Vetter Pharma, nanoBioSciences, NanoPass, Microdermics, Zosano Pharma, MyLife Technologies, Innoture Medical, Stemedica
Microneedles Drug Delivery Market | CAGR 6.6% | North America Leads with 35% Sha …
Market Overview The global microneedles drug delivery market is expected to grow at a CAGR of 6.6% during the forecast period (2023-2030). Microneedle drug delivery technology represents a transformative advancement in transdermal delivery systems, offering a minimally invasive alternative to traditional hypodermic injections. A microneedle patch consists of hundreds of microscopic needles arranged in an array that painlessly penetrates the stratum corneum, creating microchannels that allow drugs to reach the viable

All 5 Releases


More Releases for Vaccines

Vaccines Market: Information by Type (Monovalent Vaccines, Multivalent Vaccines) …
Till date, vaccines have majorly contributed to eradicating several severe diseases—smallpox and polio—from the face of the earth. During 1980–90, around millions of people died due to smallpox. Moreover, after the introduction of a worldwide End Polio Campaign, the number of polio cases has reduced to 407 in 2013 from 350,000 in 1988, the CDC. Global vaccines market was valued at USD 30.2 billion in 2018 and is expected to
Global Pet Vaccine Market By Type (Attenuated Live Vaccines, Conjugate Vaccines, …
The Global Pet Vaccine Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Pet Vaccine Market report aims to provide an overview of Pet Vaccine Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Pet Vaccine Market Economy
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,